The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-27
DOI
10.1038/s41598-020-60467-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ACG Clinical Guideline: Management of Crohn’s Disease in Adults
- (2018) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis
- (2018) Min Zhang et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies
- (2015) Judy H Cho et al. NATURE MEDICINE
- Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis
- (2015) Jing Shi et al. PHARMACOGENOMICS
- Environmental Factors in the Relapse and Recurrence of Inflammatory Bowel Disease: A Review of the Literature
- (2014) Thomas D. Martin et al. DIGESTIVE DISEASES AND SCIENCES
- Different phenotypes of theNAT2gene influences hydralazine antihypertensive response in patients with resistant hypertension
- (2014) Lizania Borges Spinasse et al. PHARMACOGENOMICS
- Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis
- (2014) M D Wiese et al. PHARMACOGENOMICS JOURNAL
- Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine
- (2014) Zhi-duo Hou et al. BMC Pharmacology & Toxicology
- NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis [Review article]
- (2012) P-Y. Wang et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Slow N-acetyltransferase 2 genotype contributes to anti-tuberculosis drug-induced hepatotoxicity: a meta-analysis
- (2012) Haijian Du et al. MOLECULAR BIOLOGY REPORTS
- Characterization of genetic variation and natural selection at the arylamineN-acetyltransferase genes in global human populations
- (2011) Holly M Mortensen et al. PHARMACOGENOMICS
- Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
- (2010) Asher Kornbluth et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Meta-analyses of small numbers of trials often agree with longer-term results
- (2010) Peter Herbison et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Effects of NAT2 polymorphism on SASP pharmacokinetics in Chinese population
- (2009) Jing-Jing Ma et al. CLINICA CHIMICA ACTA
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Update on the pharmacogenetics of NATs: structural considerations
- (2008) Lesley A Stanley et al. PHARMACOGENOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started